Using [18F]flortaucipir PET, Vogel et al. (2020) showed that tau pathology was accompanied by neuronal loss and consequent shrinkage of the brain, especially in the cortex and hippocampus of patients with AD. The gene discussed is MAPT; the disease is Alzheimer disease.